Exclusive: Seltz, a startup trying to reinvent web search for AI agents, raises $12.5 seed roundJune 24, 2026
TCR2 Therapeutics stock rises 16% as cell therapy for solid tumors shows promise in trial Markets September 28, 2022 gorodenkoff TCR2 Therapeutics (NASDAQ:TCRR) stated its cell remedy gavo-cel confirmed medical profit in sufferers with mesothelin-expressing strong tumors in a…
